$9.32 Billion is the total value of Perceptive Advisors's 139 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 51.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MRTX | Buy | MIRATI THERAPEUTICS INC | $811,244,000 | +42.2% | 3,693,516 | +7.5% | 8.71% | +4.5% |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $579,837,000 | +63.5% | 25,112,048 | -0.0% | 6.22% | +20.2% |
| BBIO | BRIDGEBIO PHARMA INC | $476,883,000 | +89.5% | 6,706,268 | 0.0% | 5.12% | +39.3% | |
| RETROPHIN INCnote 2.500% 9/1 | $442,521,000 | +13.4% | 45,000,000 | 0.0% | 4.75% | -16.6% | ||
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $425,316,000 | +28.1% | 9,166,304 | -9.1% | 4.56% | -5.8% |
| NVTA | New | INVITAE CORP | $304,563,000 | – | 7,284,466 | +100.0% | 3.27% | – |
| SWTX | Buy | SPRINGWORKS THERAPEUTICS INC | $302,968,000 | +82.6% | 4,177,721 | +20.0% | 3.25% | +34.2% |
| GBT | Sell | GLOBAL BLOOD THERAPEUTICS IN | $245,771,000 | -23.2% | 5,674,711 | -2.2% | 2.64% | -43.5% |
| HZNP | New | HORIZON THERAPEUTICS PUB L | $225,597,000 | – | 3,084,042 | +100.0% | 2.42% | – |
| ZYME | Sell | ZYMEWORKS INC | $203,265,000 | -0.8% | 4,300,999 | -2.3% | 2.18% | -27.1% |
| RCKT | Buy | ROCKET PHARMACEUTICALS INC | $186,284,000 | +272.3% | 3,396,867 | +55.2% | 2.00% | +173.5% |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $182,040,000 | +22.2% | 1,899,215 | +22.6% | 1.95% | -10.1% |
| COLLEGIUM PHARMACEUTICAL INCnote 2.625% 2/1 | $173,250,000 | +5.8% | 17,500,000 | 0.0% | 1.86% | -22.3% | ||
| NVRO | Buy | NEVRO CORP | $169,217,000 | +47.0% | 977,565 | +18.3% | 1.82% | +8.1% |
| NEVRO CORPnote 2.750% 4/0 | $165,420,000 | +16.6% | 9,000,000 | 0.0% | 1.78% | -14.3% | ||
| OM | OUTSET MED INC | $161,870,000 | +13.7% | 2,847,822 | 0.0% | 1.74% | -16.5% | |
| VBIV | VBI VACCINES INC | $151,366,000 | -3.8% | 55,042,465 | 0.0% | 1.62% | -29.3% | |
| ATNX | ATHENEX INC | $149,669,000 | -7.2% | 13,532,467 | 0.0% | 1.61% | -31.8% | |
| AVIR | New | ATEA PHARMACEUTICALS INC | $129,903,000 | – | 3,109,224 | +100.0% | 1.39% | – |
| NVAX | Buy | NOVAVAX INC | $116,305,000 | +51.7% | 1,043,000 | +47.4% | 1.25% | +11.4% |
| FREQ | Buy | FREQUENCY THERAPEUTICS INC | $114,935,000 | +83.7% | 3,259,635 | +0.1% | 1.23% | +35.0% |
| KOD | Sell | KODIAK SCIENCES INC | $110,408,000 | +78.8% | 751,533 | -27.9% | 1.18% | +31.4% |
| ATHA | ATHIRA PHARMA INC | $106,682,000 | +85.5% | 3,114,805 | 0.0% | 1.14% | +36.5% | |
| MGTX | Buy | MEIRAGTX HLDGS PLC | $104,970,000 | +23.2% | 6,933,277 | +7.8% | 1.13% | -9.5% |
| CCCC | New | C4 THERAPEUTICS INC | $104,643,000 | – | 3,158,566 | +100.0% | 1.12% | – |
| RLAY | RELAY THERAPEUTICS INC | $96,810,000 | -2.4% | 2,329,407 | 0.0% | 1.04% | -28.2% | |
| TVTX | New | TRAVERE THERAPEUTICS INC | $95,218,000 | – | 3,493,607 | +100.0% | 1.02% | – |
| EIDX | EIDOS THERAPEUTICS INC | $90,385,000 | +160.4% | 686,922 | 0.0% | 0.97% | +91.3% | |
| ALBO | ALBIREO PHARMA INC | $88,529,000 | +12.4% | 2,360,139 | 0.0% | 0.95% | -17.4% | |
| QTNT | QUOTIENT LTD | $84,406,000 | +1.4% | 16,200,818 | 0.0% | 0.91% | -25.5% | |
| KRON | New | KRONOS BIO INC | $83,041,000 | – | 2,780,097 | +100.0% | 0.89% | – |
| ARWR | New | ARROWHEAD PHARMACEUTICALS IN | $82,164,000 | – | 1,070,814 | +100.0% | 0.88% | – |
| SLDB | Buy | SOLID BIOSCIENCES INC | $81,893,000 | +497.7% | 10,803,857 | +60.1% | 0.88% | +339.5% |
| CHRS | Buy | COHERUS BIOSCIENCES INC | $81,197,000 | +21.7% | 4,671,836 | +28.5% | 0.87% | -10.6% |
| CERE | New | CEREVEL THERAPEUTICS HLDNG I | $75,340,000 | – | 4,544,062 | +100.0% | 0.81% | – |
| PRVB | Sell | PROVENTION BIO INC | $71,561,000 | +30.8% | 4,224,389 | -1.0% | 0.77% | -3.9% |
| KDMN | KADMON HLDGS INC | $65,202,000 | +5.9% | 15,711,334 | 0.0% | 0.70% | -22.1% | |
| IMVT | IMMUNOVANT INC | $64,666,000 | +31.3% | 1,400,000 | 0.0% | 0.69% | -3.5% | |
| ONCR | New | ONCORUS INC | $64,336,000 | – | 1,989,987 | +100.0% | 0.69% | – |
| NARI | Sell | INARI MED INC | $58,353,000 | -0.4% | 668,500 | -21.2% | 0.63% | -26.8% |
| PMVP | Buy | PMV PHARMACEUTICALS INC | $54,471,000 | +153.4% | 885,556 | +46.2% | 0.58% | +86.3% |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | $54,537,000 | +58.9% | 1,050,003 | 0.0% | 0.58% | +16.8% | |
| TARS | New | TARSUS PHARMACEUTICALS INC | $53,580,000 | – | 1,296,416 | +100.0% | 0.58% | – |
| ADPT | Buy | ADAPTIVE BIOTECHNOLOGIES COR | $53,504,000 | +32.6% | 904,854 | +9.0% | 0.57% | -2.5% |
| CRNX | CRINETICS PHARMACEUTICALS IN | $51,634,000 | -10.0% | 3,659,381 | 0.0% | 0.55% | -33.8% | |
| UROV | Buy | UROVANT SCIENCES LTD | $50,274,000 | +127.4% | 3,116,831 | +31.7% | 0.54% | +67.2% |
| CMPS | COMPASS PATHWAYS PLCsponsored ads | $49,898,000 | +36.5% | 1,047,404 | 0.0% | 0.54% | +0.2% | |
| AGRX | AGILE THERAPEUTICS INC | $45,690,000 | -5.6% | 15,919,925 | 0.0% | 0.49% | -30.7% | |
| ARNA | Sell | ARENA PHARMACEUTICALS INC | $44,178,000 | -5.5% | 575,007 | -8.0% | 0.47% | -30.6% |
| FMTX | FORMA THERAPEUTICS HLDGS INC | $43,625,000 | -30.0% | 1,250,000 | 0.0% | 0.47% | -48.6% | |
| ALDX | ALDEYRA THERAPEUTICS INC | $43,118,000 | -7.4% | 6,285,458 | 0.0% | 0.46% | -31.9% | |
| STOK | STOKE THERAPEUTICS INC | $41,616,000 | +84.9% | 671,978 | 0.0% | 0.45% | +35.9% | |
| COLL | COLLEGIUM PHARMACEUTICAL INC | $41,223,000 | -3.8% | 2,058,068 | 0.0% | 0.44% | -29.4% | |
| VRCA | VERRICA PHARMACEUTICALS INC | $39,254,000 | +48.7% | 3,410,412 | 0.0% | 0.42% | +9.4% | |
| SAGE | New | SAGE THERAPEUTICS INC | $38,064,000 | – | 440,000 | +100.0% | 0.41% | – |
| LYRA | LYRA THERAPEUTICS INC | $36,737,000 | +2.0% | 3,222,561 | 0.0% | 0.39% | -25.1% | |
| VYNE | VYNE THERAPEUTICS INC | $36,145,000 | -4.8% | 22,876,410 | 0.0% | 0.39% | -30.0% | |
| COGT | New | COGENT BIOSCIENCES INC | $35,810,000 | – | 3,188,750 | +100.0% | 0.38% | – |
| NEPT | Buy | NEPTUNE WELLNESS SOLUTIONS I | $34,655,000 | -15.5% | 22,214,683 | +14.3% | 0.37% | -37.9% |
| ADMA | ADMA BIOLOGICS INC | $32,340,000 | -18.4% | 16,584,802 | 0.0% | 0.35% | -40.1% | |
| RNA | AVIDITY BIOSCIENCES INC | $31,538,000 | -9.3% | 1,235,818 | 0.0% | 0.34% | -33.5% | |
| RAPT | New | RAPT THERAPEUTICS INC | $31,155,000 | – | 1,577,481 | +100.0% | 0.33% | – |
| ISEE | Buy | IVERIC BIO INC | $30,976,000 | +57.8% | 4,482,713 | +28.8% | 0.33% | +15.7% |
| SILK | Sell | SILK RD MED INC | $29,292,000 | -16.2% | 465,100 | -10.6% | 0.31% | -38.4% |
| ALLO | ALLOGENE THERAPEUTICS INC | $28,869,000 | -33.1% | 1,143,790 | 0.0% | 0.31% | -50.8% | |
| MGNX | Sell | MACROGENICS INC | $28,828,000 | -11.4% | 1,261,060 | -2.3% | 0.31% | -34.9% |
| XBI | SPDR SER TRput | $28,156,000 | +26.3% | 200,000 | 0.0% | 0.30% | -7.1% | |
| VERU | Buy | VERU INC | $28,113,000 | +550.3% | 3,250,000 | +97.0% | 0.30% | +379.4% |
| ACCD | Buy | ACCOLADE INC | $27,256,000 | +139.2% | 626,591 | +113.8% | 0.29% | +76.5% |
| CNCE | CONCERT PHARMACEUTICALS INC | $27,184,000 | +28.7% | 2,150,641 | 0.0% | 0.29% | -5.2% | |
| IMTX | IMMATICS N.V | $26,975,000 | +1.7% | 2,500,000 | 0.0% | 0.29% | -25.3% | |
| REGN | Buy | REGENERON PHARMACEUTICALS | $26,656,000 | +852.3% | 55,175 | +1003.5% | 0.29% | +597.6% |
| LUNG | New | PULMONX CORP | $26,573,000 | – | 385,000 | +100.0% | 0.28% | – |
| FUSN | FUSION PHARMACEUTICALS INC | $26,273,000 | -2.2% | 2,235,983 | 0.0% | 0.28% | -28.1% | |
| ESTA | Buy | ESTABLISHMENT LABS HLDGS INC | $26,221,000 | +108.5% | 696,633 | +2.7% | 0.28% | +52.7% |
| ANAB | New | ANAPTYSBIO INC | $25,700,000 | – | 1,195,336 | +100.0% | 0.28% | – |
| FDMT | New | 4D MOLECULAR THERAPEUTICS IN | $24,881,000 | – | 600,256 | +100.0% | 0.27% | – |
| ONEM | Buy | 1LIFE HEALTHCARE INC | $22,691,000 | +185.9% | 519,844 | +85.8% | 0.24% | +110.3% |
| NSTG | New | NANOSTRING TECHNOLOGIES INC | $22,592,000 | – | 337,800 | +100.0% | 0.24% | – |
| PCVX | VAXCYTE INC | $22,585,000 | -46.2% | 850,000 | 0.0% | 0.24% | -60.5% | |
| GERN | GERON CORP | $21,404,000 | -8.6% | 13,461,538 | 0.0% | 0.23% | -32.7% | |
| RACA | THERAPEUTICS ACQUISITION COR | $20,880,000 | -3.2% | 1,500,000 | 0.0% | 0.22% | -28.9% | |
| AMRS | AMYRIS INC | $20,583,000 | +140.2% | 3,333,332 | 0.0% | 0.22% | +76.8% | |
| VRNA | VERONA PHARMA PLCsponsored ads | $20,222,000 | +12.2% | 2,888,889 | 0.0% | 0.22% | -17.5% | |
| WVE | WAVE LIFE SCIENCES LTD | $19,675,000 | -7.3% | 2,500,000 | 0.0% | 0.21% | -31.9% | |
| LPTX | LEAP THERAPEUTICS INC | $19,072,000 | +13.6% | 8,476,496 | 0.0% | 0.20% | -16.3% | |
| VTRS | New | VIATRIS INC | $18,823,000 | – | 1,004,419 | +100.0% | 0.20% | – |
| RGEN | New | REPLIGEN CORP | $18,684,000 | – | 97,500 | +100.0% | 0.20% | – |
| SCYX | New | SCYNEXIS INC | $18,360,000 | – | 2,400,000 | +100.0% | 0.20% | – |
| NBTX | New | NANOBIOTIX SAsponsored ads | $18,150,000 | – | 1,100,000 | +100.0% | 0.20% | – |
| HRMY | Buy | HARMONY BIOSCIENCES HLDGS IN | $18,170,000 | +23.1% | 502,622 | +15.4% | 0.20% | -9.3% |
| DRNA | DICERNA PHARMACEUTICALS INC | $17,624,000 | +22.5% | 800,000 | 0.0% | 0.19% | -10.0% | |
| DBVT | Sell | DBV TECHNOLOGIES S Asponsored adr | $17,280,000 | +46.7% | 6,595,505 | -3.1% | 0.18% | +7.6% |
| CTMX | CYTOMX THERAPEUTICS INC | $16,880,000 | -1.5% | 2,577,043 | 0.0% | 0.18% | -27.6% | |
| MORF | MORPHIC HLDG INC | $16,339,000 | +22.7% | 487,000 | 0.0% | 0.18% | -9.8% | |
| LGVWU | LONGVIEW ACQUISITION CORPunit 99/99/9999 | $15,155,000 | +113.3% | 700,000 | 0.0% | 0.16% | +56.7% | |
| TARA | PROTARA THERAPEUTICS INC | $14,733,000 | +43.8% | 608,544 | 0.0% | 0.16% | +5.3% | |
| PPH | VANECK VECTORS ETF TRput | $13,294,000 | +6.9% | 200,000 | 0.0% | 0.14% | -21.4% | |
| AMWL | Buy | AMERICAN WELL CORPcl a | $13,298,000 | -1.4% | 525,000 | +15.4% | 0.14% | -27.4% |
| FBRX | New | FORTE BIOSCIENCES INC | $12,744,000 | – | 350,000 | +100.0% | 0.14% | – |
| TSHA | TAYSHA GENE THERAPIES INC | $12,485,000 | +18.5% | 470,440 | 0.0% | 0.13% | -13.0% | |
| TCRR | TCR2 THERAPEUTICS INC | $12,372,000 | +52.2% | 400,000 | 0.0% | 0.13% | +11.8% | |
| HCAT | Sell | HEALTH CATALYST INC | $12,018,000 | +12.8% | 276,084 | -5.2% | 0.13% | -17.3% |
| BLSA | New | BCLS ACQUISITION CORP | $11,140,000 | – | 1,000,000 | +100.0% | 0.12% | – |
| SCPEU | SC HEALTH CORPunit 99/99/9999 | $10,990,000 | +3.7% | 1,000,000 | 0.0% | 0.12% | -23.9% | |
| CRIS | New | CURIS INC | $10,238,000 | – | 1,250,000 | +100.0% | 0.11% | – |
| MRVI | New | MARAVAI LIFESCIENCES HLDGS I | $9,818,000 | – | 350,000 | +100.0% | 0.10% | – |
| VRAY | VIEWRAY INC | $9,366,000 | +9.1% | 2,451,748 | 0.0% | 0.10% | -19.2% | |
| RVMD | REVOLUTION MEDICINES INC | $8,877,000 | +13.8% | 224,224 | 0.0% | 0.10% | -16.7% | |
| PSTX | POSEIDA THERAPEUTICS INC | $8,642,000 | +23.7% | 787,745 | 0.0% | 0.09% | -8.8% | |
| DYN | DYNE THERAPEUTICS INC | $8,400,000 | +4.0% | 400,000 | 0.0% | 0.09% | -23.7% | |
| SHC | New | SOTERA HEALTH CO | $8,232,000 | – | 300,000 | +100.0% | 0.09% | – |
| AQST | Sell | AQUESTIVE THERAPEUTICS INC | $7,414,000 | -12.7% | 1,385,720 | -20.8% | 0.08% | -35.5% |
| SNDX | New | SYNDAX PHARMACEUTICALS INC | $6,672,000 | – | 300,000 | +100.0% | 0.07% | – |
| VINC | New | VINCERA PHARMA INC | $6,273,000 | – | 300,000 | +100.0% | 0.07% | – |
| SGTX | New | SIGILON THERAPEUTICS INC | $6,004,000 | – | 125,000 | +100.0% | 0.06% | – |
| HSAQ | HEALTH SCIENCES ACQ CORP 2 | $5,765,000 | +16.5% | 450,000 | 0.0% | 0.06% | -13.9% | |
| BCTG | BCTG ACQUISITION CORP | $5,720,000 | +10.4% | 500,000 | 0.0% | 0.06% | -19.7% | |
| PHR | New | PHREESIA INC | $5,426,000 | – | 100,000 | +100.0% | 0.06% | – |
| CHFWU | New | CONSONANCE HFW ACQUISITION Cunit 99/99/9999 | $5,235,000 | – | 500,000 | +100.0% | 0.06% | – |
| DFHTU | DEERFIELD HEALTHCARE TECH ACunit 07/16/2025 | $4,500,000 | +41.1% | 300,000 | 0.0% | 0.05% | +2.1% | |
| MASS | New | 908 DEVICES INC | $4,414,000 | – | 77,500 | +100.0% | 0.05% | – |
| AVXL | New | ANAVEX LIFE SCIENCES CORP | $4,212,000 | – | 780,007 | +100.0% | 0.04% | – |
| PTGX | New | PROTAGONIST THERAPEUTICS INC | $4,104,000 | – | 203,591 | +100.0% | 0.04% | – |
| MOTS | MOTUS GI HLDGS INC | $3,906,000 | -3.0% | 4,210,542 | 0.0% | 0.04% | -28.8% | |
| MTEM | Sell | MOLECULAR TEMPLATES INC | $3,867,000 | -85.7% | 411,818 | -83.4% | 0.04% | -89.6% |
| BNR | BURNING ROCK BIOTECH LTDsponsored ads | $3,465,000 | -7.9% | 150,000 | 0.0% | 0.04% | -32.7% | |
| GRTX | GALERA THERAPEUTICS INC | $3,325,000 | +13.2% | 325,000 | 0.0% | 0.04% | -16.3% | |
| LSAQ | New | LIFESCI ACQUISITION II CORP | $3,201,000 | – | 300,000 | +100.0% | 0.03% | – |
| ADAP | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $2,156,000 | -32.5% | 400,000 | 0.0% | 0.02% | -51.1% | |
| EIGR | EIGER BIOPHARMACEUTICALS INC | $1,719,000 | +51.1% | 139,890 | 0.0% | 0.02% | +5.9% | |
| RACE | FERRARI N V | $1,423,000 | +24.7% | 6,200 | 0.0% | 0.02% | -11.8% | |
| VINCW | New | VINCERA PHARMA INC*w exp 12/24/202 | $990,000 | – | 300,000 | +100.0% | 0.01% | – |
| SRRA | SIERRA ONCOLOGY INC | $1,068,000 | +50.2% | 66,655 | 0.0% | 0.01% | +10.0% | |
| ABCL | New | ABCELLERA BIOLOGICS INC | $805,000 | – | 20,000 | +100.0% | 0.01% | – |
| LEGN | LEGEND BIOTECH CORPsponsored ads | $704,000 | -8.8% | 25,000 | 0.0% | 0.01% | -27.3% | |
| IPOF | New | SOCIAL CAPITAL HEDOSOPHIA HLD | $671,000 | – | 40,000 | +100.0% | 0.01% | – |
| DFHT | New | DEERFIELD HEALTHCARE TECH AC | $312,000 | – | 20,000 | +100.0% | 0.00% | – |
| OTLKW | OUTLOOK THERAPEUTICS INC*w exp 02/18/202 | $93,000 | +72.2% | 420,875 | 0.0% | 0.00% | 0.0% | |
| BIO | Exit | BIO RAD LABS INCcl a | $0 | – | -489 | -100.0% | -0.00% | – |
| REPL | Exit | REPLIMUNE GROUP INC | $0 | – | -19,230 | -100.0% | -0.01% | – |
| CVET | Exit | COVETRUS INC | $0 | – | -26,075 | -100.0% | -0.01% | – |
| PSNL | Exit | PERSONALIS INC | $0 | – | -27,272 | -100.0% | -0.01% | – |
| AKRO | Exit | AKERO THERAPEUTICS INC | $0 | – | -21,938 | -100.0% | -0.01% | – |
| CLDX | Exit | CELLDEX THERAPEUTICS INC NEW | $0 | – | -49,751 | -100.0% | -0.01% | – |
| TGTX | Exit | TG THERAPEUTICS INC | $0 | – | -33,893 | -100.0% | -0.01% | – |
| LVGO | Exit | LIVONGO HEALTH INC | $0 | – | -10,663 | -100.0% | -0.02% | – |
| Exit | TRILLIUM THERAPEUTICS INC | $0 | – | -114,674 | -100.0% | -0.02% | – | |
| ATEC | Exit | ALPHATEC HLDGS INC | $0 | – | -561,574 | -100.0% | -0.05% | – |
| LSACU | Exit | LIFESCI ACQUISITION CORPunit 03/31/2025 | $0 | – | -300,000 | -100.0% | -0.06% | – |
| TBIO | Exit | TRANSLATE BIO INC | $0 | – | -315,237 | -100.0% | -0.06% | – |
| TWST | Exit | TWIST BIOSCIENCE CORP | $0 | – | -112,756 | -100.0% | -0.12% | – |
| ATRC | Exit | ATRICURE INC | $0 | – | -216,449 | -100.0% | -0.13% | – |
| PODD | Exit | INSULET CORP | $0 | – | -37,733 | -100.0% | -0.13% | – |
| HOLX | Exit | HOLOGIC INC | $0 | – | -170,000 | -100.0% | -0.16% | – |
| MYL | Exit | MYLAN N.V | $0 | – | -1,004,419 | -100.0% | -0.22% | – |
| UMRX | Exit | UNUM THERAPEUTICS INC | $0 | – | -7,955,000 | -100.0% | -0.27% | – |
| BIIB | Exit | BIOGEN INCcall | $0 | – | -100,000 | -100.0% | -0.41% | – |
| TPTX | Exit | TURNING POINT THERAPEUTICS I | $0 | – | -329,890 | -100.0% | -0.42% | – |
| RTRX | Exit | RETROPHIN INC | $0 | – | -3,240,112 | -100.0% | -0.87% | – |
| BPMC | Exit | BLUEPRINT MEDICINES CORP | $0 | – | -664,574 | -100.0% | -0.90% | – |
| IMMU | Exit | IMMUNOMEDICS INC | $0 | – | -912,140 | -100.0% | -1.13% | – |
| CRSP | Exit | CRISPR THERAPEUTICS AGnamen akt | $0 | – | -1,341,308 | -100.0% | -1.64% | – |
| MYOK | Exit | MYOKARDIA INC | $0 | – | -1,395,017 | -100.0% | -2.78% | – |
| Exit | CYTOKINETICS INCnote 4.000%11/1 | $0 | – | -9,770,000 | -100.0% | -3.19% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
About Perceptive Advisors
Perceptive Advisors is a New York-based hedge fund that specializes in healthcare investments. The company was founded in 1999 by Joseph Edelman, who serves as the CEO and Chief Investment Officer. Since its inception, Perceptive Advisors has become one of the most successful healthcare-focused hedge funds in the world, with over $5 billion in assets under management.
The company's investment strategy is based on a deep understanding of the healthcare industry and a focus on identifying promising companies with innovative products and technologies. Perceptive Advisors invests in a wide range of healthcare sectors, including biotechnology, pharmaceuticals, medical devices, and healthcare services.
One of the key factors behind Perceptive Advisors' success is its team of experienced professionals. In addition to Joseph Edelman, the company's leadership team includes Adam Stone, the COO, and Jeremy Goldberg, the Chief Scientific Officer. The team also includes a group of highly skilled analysts and researchers who are experts in their respective fields.
Perceptive Advisors has a strong track record of generating high returns for its investors. However, it is important to note that investing in hedge funds carries significant risks, and investors should carefully consider their investment objectives and risk tolerance before investing. As with any investment, it is important to conduct thorough research and seek the advice of a qualified financial advisor before making any investment decisions.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES SHARES | 42 | Q3 2023 | 15.7% |
| AMICUS THERAPEUTICS SHARES | 39 | Q3 2023 | 14.0% |
| ALDEYRA THERAPEUTICS SHARES | 35 | Q3 2023 | 3.3% |
| QUOTIENT TECHNOLOGY INC | 34 | Q3 2022 | 2.7% |
| GLOBAL BLOOD THERAPEUTICS SHARES | 29 | Q3 2022 | 9.3% |
| ADMA BIOLOGICS SHARES | 29 | Q3 2023 | 1.4% |
| RETROPHIN SHARES | 28 | Q3 2020 | 5.5% |
| DBV TECHNOLOGIES SA-SPON ADR | 28 | Q3 2021 | 1.8% |
| VBI VACCINES SHARES | 27 | Q1 2023 | 2.8% |
| IOVANCE BIOTHERAPEUTICS INC | 26 | Q3 2023 | 9.1% |
View Perceptive Advisors's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| CHEMBIO DIAGNOSTICS, INC.Sold out | May 04, 2023 | 0 | 0.0% |
| VBI Vaccines Inc/BC | April 07, 2023 | 43,509,553 | 16.7% |
| Landos Biopharma, Inc. | March 30, 2023 | 14,869,915 | 47.7% |
| REATA PHARMACEUTICALS INC | March 07, 2023 | 2,083,799 | 6.5% |
| AGILE THERAPEUTICS INCSold out | February 14, 2023 | 0 | 0.0% |
| ALBIREO PHARMA, INC. | February 14, 2023 | 1,757,160 | 8.5% |
| BELLUS Health Inc. | February 14, 2023 | 8,891,027 | 7.1% |
| CinCor Pharma, Inc. | February 14, 2023 | 2,576,325 | 5.9% |
| Coherus BioSciences, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| CONCERT PHARMACEUTICALS, INC. | February 14, 2023 | 1,800,000 | 3.6% |
View Perceptive Advisors's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-17 |
| SC 13D/A | 2024-04-17 |
| 4 | 2024-04-15 |
| SC 13G/A | 2024-04-15 |
| SC 13G | 2024-04-15 |
| SC 13D/A | 2024-04-10 |
| 4 | 2024-04-08 |
| 4 | 2024-04-03 |
| SC 13D/A | 2024-04-03 |
| SC 13D | 2024-03-20 |
View Perceptive Advisors's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.